---
figid: PMC10558228__ijmm-52-5-05314-g04
figtitle: Targeting inflammatory signaling pathways with drugs shows promise in AD
  treatment
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10558228
filename: PMC10558228__ijmm-52-5-05314-g04.jpg
figlink: /pmc/articles/PMC10558228/figure/F5
number: F5
caption: Targeting inflammatory signaling pathways with drugs shows promise in AD
  treatment. By modulating various signaling pathways, drugs and inhibitors can effectively
  target microglia, neurons, and mice with AD. This targeted approach helps regulate
  inflammatory responses, promote neuronal survival, and restore functional recovery,
  ultimately alleviating symptoms of AD. AD, Alzheimer's disease; NLRP3, NOD-like
  receptor thermal protein domain associated protein 3; CREB, cyclic AMP response
  element binding; PPAR, Peroxisome proliferator-activated receptor; Nrf2, Nuclear
  factor erythroid 2-related factor 2.
papertitle: Inflammatory signaling pathways in the treatment of Alzheimer's disease
  with inhibitors, natural products and metabolites (Review)
reftext: Yujia Zheng, et al. Int J Mol Med. 2023 Nov;52(5).
year: '2023'
doi: 10.3892/ijmm.2023.5314
journal_title: International Journal of Molecular Medicine
journal_nlm_ta: Int J Mol Med
publisher_name: D.A. Spandidos
keywords: Alzheimer's disease | neuroinflammation | inhibitor | inflammatory signaling
  pathways | treatment
automl_pathway: 0.8770396
figid_alias: PMC10558228__F5
figtype: Figure
redirect_from: /figures/PMC10558228__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10558228__ijmm-52-5-05314-g04.html
  '@type': Dataset
  description: Targeting inflammatory signaling pathways with drugs shows promise
    in AD treatment. By modulating various signaling pathways, drugs and inhibitors
    can effectively target microglia, neurons, and mice with AD. This targeted approach
    helps regulate inflammatory responses, promote neuronal survival, and restore
    functional recovery, ultimately alleviating symptoms of AD. AD, Alzheimer's disease;
    NLRP3, NOD-like receptor thermal protein domain associated protein 3; CREB, cyclic
    AMP response element binding; PPAR, Peroxisome proliferator-activated receptor;
    Nrf2, Nuclear factor erythroid 2-related factor 2.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NLRP3
  - PPARA
  - PPARD
  - PPARG
  - PERCC1
  - ICAM4-AS1
  - APP
  - MAPT
  - MICE
  - C6
  - NFKB1
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - STAT3
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - GABPA
  - NFE2L2
  - Organic compounds
  - Tau
  - disease
  - Alzheimers disease
---
